(Q45382094)

English

Reduction in hepatitis B virus seroprevalence among U.S.-born children of foreign-born Asian parents -- benefit of universal infant hepatitis B vaccination

scientific article published on 11 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Reduction in hepatitis B virus seroprevalence among U.S.-born children of foreign-born Asian parents -- benefit of universal infant hepatitis B vaccination (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Carrie M Shuler

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Anthony E Fiore

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Ruth Neeman

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Beth P Bell

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Wendi Kuhnert

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sandra Watkins

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Kimberly Kilgour

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Kathryn E Arnold

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

11 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

5942-5947

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Risks of chronicity following acute hepatitis B virus infection: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Epidemiology of hepatitis B and hepatitis B virus infection in United States children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Global epidemiology of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Hepatitis B virus infection among children born in the United States to Southeast Asian refugees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Childhood hepatitis B virus infections in the United States before hepatitis B immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Postnatal infectivity of hepatitis B surface antigen-carrier mothers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Hepatitis B virus infection: epidemiology and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.087

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.07.087

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45382094&oldid=2076275030"